PRESS-RELEASE ·Filed Aug 3, 2026
Press release: earnings
Actionable Insight • Neutral
The actual Q2 2026 earnings results will be released on August 6, 2026. Traders should monitor that release for material financial data and guidance updates, as this filing contains no actionable numbers.
Latest settled — T+20d
RGNX ▼ -4.62% at T+20d
NEUTRAL call ✗ call lost -4.62% · α vs SPY -5.86% · entry $9.96 → $9.50
Latest observation: T+39 -32.05% FF3 residual α
T+1d
+3.41%
call +3.41% · α +1.61%
$10.30
settled 8w ago
T+5d
+4.62%
call +4.62% · α +2.59%
$10.42
settled 8w ago
T+20d
-4.62%
call -4.62% · α -5.86%
$9.50
settled 5w ago
T+60d
—
call — · α —
—
in 25d
Price Chart
Loading chart...
Executive Summary
REGENXBIO issued a press release announcing a conference call on August 6, 2026, to discuss Q2 2026 financial results and operational highlights. No financial data or guidance was disclosed in this filing.
Key Facts
- Conference call scheduled for August 6, 2026 at 8:00 AM ET
- Call will cover Q2 2026 financial results and operational highlights
- No financial results or guidance included in this filing
Financial Impact
No financial data disclosed
Risk Factors
- No financial information provided to assess performance
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
89% bullish (19 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302840354 |
10 reports for RGNX
40% Hit rate best @ T+5▲ +25.36%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | Insider Buy | $9.66 $7.47 | ▼ −22.67% | ▼ −22.93% | $7.51 (−22.31%) |
Aug 25, 2026 5w ago | 8-K | $9.38 $7.24 | ▼ −22.81% | ▼ −23.04% | $7.51 (−19.99%) |
Aug 6, 2026 8w ago | 8-K | $11.28 $9.20 | ▼ −18.44% | ▼ −19.04% | $7.51 (−33.47%) |
Aug 3, 2026 8w ago | Press Release | $9.96 $9.50 | ▼ −4.62% | ▼ −5.86% | $7.51 (−24.65%) |
Jul 20, 2026 10w ago | 8-K | $10.32 $11.33 | ▼ −9.79% | ▼ −5.67% | $7.51 (+27.28%) |
Jul 17, 2026 11w ago | Press Release | $9.89 $10.77 | ▼ −8.85% | ▼ −4.40% | $7.51 (+24.12%) |
Jun 29, 2026 13w ago | 8-K | $11.83 $9.73 | ▼ −17.75% | ▼ −17.47% | $7.51 (−36.56%) |
Jun 3, 2026 17w ago | 8-K | $6.69 $13.28 | ▲ +98.51% | ▲ +99.51% | $7.51 (+12.18%) |
May 14, 2026 20w ago | 8-K | $6.25 $6.66 | ▲ +6.65% | ▲ +7.50% | $7.51 (+20.18%) |
Mar 5, 2026 30w ago | 8-K | $8.72 $8.53 | ▼ −2.18% | ▲ +1.61% | $7.51 (−13.93%) |
Showing 10 of 10
US Market Status
Market Open — Closes in 1h 59m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access